Year: 2018
Type: dissertation
Abstract: NUAK1 (aka ARK5) is a member of the AMPK-related kinase family and has been associated with many essential cellular processes that are often perturbed in cancer.Elevated NUAK1 expression has been observed in advanced stages of colorectal cancer (CRC) and is further enriched in liver metastasis in human patients.Therefore, NUAK1 is a novel tumour progression-associated factor, however, its primary function in this context and its use as a potential therapeutic target remains unclear.NUAK1 was previously identified as synthetic lethal in MYC-overexpressing tumour cells.This study shows that high NUAK1 levels correspond to poor patient survival in human CRC, and that increased NUAK1 RNA correlates with advanced tumour stages in a human TMA of CRC.Using mouse models of CRC, it is demonstrated that Nuak1 deletion inhibits colon tumour initiation, and acute depletion of Nuak1 by shRNA in established tumours significantly reduces tumour burden after just 7 days of shRNA activation.Interrogation of tumours acutely depleted of Nuak1 showed decreased cell proliferation concurrent with increased ROS and cell death.Interestingly, the requirement for Nuak1 did not extend to healthy wildtype intestine; depletion of Nuak1 in mouse intestine had no impact on cell death, proliferation or differentiation, and wildtype 3D organoids were resistant to Nuak1 inhibition.Using human CRC cell Bibliography ...
Author: Jennifer Port
Institution: University of Glasgow
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2804234586
